Free Trial
Your $100 Credit Expires Tomorrow! Get MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion
Wedbush

Wedbush Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Wedbush. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Wedbush's equity research team. MarketBeat is not affiliated with or endorsed by Wedbush.

Average Return
00.00% 12-Month ROI
Total Ratings
918 Last 12 Months
Buy Ratings
716 Last 12 Months
Sell Ratings
19 Last 12 Months
Companies Covered
282 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
International Business Machines Corporation stock logo
IBM
International Business Machines
$253.88
+0.4%
5/21/2026Reiterated RatingOutperformView details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/21/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$215.33
-1.9%
5/21/2026Boost Price Target$300.00 ➝ $330.00OutperformView details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/21/2026
Globant S.A. stock logo
GLOB
Globant
$40.14
-1.2%
5/18/2026Reiterated RatingOutperformView details for Wedbush rating of Globant (NYSE:GLOB) on 5/18/2026
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$3.45
-3.4%
5/18/2026Lower Price Target$13.00 ➝ $12.00OutperformView details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 5/18/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$215.33
-1.9%
5/18/2026Reiterated Rating$300.00BuyView details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/18/2026
Globant S.A. stock logo
GLOB
Globant
$40.14
-1.2%
5/15/2026Set Price Target$54.00View details for Wedbush rating of Globant (NYSE:GLOB) on 5/15/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$41.33
+5.6%
5/15/2026 Set Price Target$48.00View details for Wedbush rating of Dynatrace (NYSE:DT) on 5/15/2026
Solventum Corporation stock logo
SOLV
Solventum
$76.92
+0.2%
5/15/2026Initiated Coverage$94.00OutperformView details for Wedbush rating of Solventum (NYSE:SOLV) on 5/15/2026
Starbucks Corporation stock logo
SBUX
Starbucks
$103.11
-1.0%
5/14/2026 Initiated CoverageNeutralOutperformView details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 5/14/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$21.22
-1.5%
5/14/2026Boost Price Target$21.00 ➝ $24.00NeutralView details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 5/14/2026
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
$4.92
-3.9%
5/14/2026Initiated Coverage$17.00OutperformView details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026
Aprea Therapeutics, Inc. stock logo
APRE
Aprea Therapeutics
$0.95
+2.2%
5/14/2026Lower Price Target$7.00 ➝ $6.00OutperformView details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 5/14/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$16.35
-1.5%
5/14/2026Lower Price Target$40.00 ➝ $34.00OutperformView details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026
Innodata Inc. stock logo
INOD
Innodata
$95.48
-3.1%
5/14/2026Boost Price Target$80.00 ➝ $100.00OutperformView details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/14/2026
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
$4.92
-3.9%
5/14/2026Initiated Coverage$17.00OutperformView details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026
Planet Labs PBC stock logo
PL
Planet Labs PBC
$44.39
+4.5%
5/14/2026Boost Price Target$40.00 ➝ $50.00OutperformView details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 5/14/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$32.47
-1.0%
5/14/2026Upgrade$26.00 ➝ $40.00NeutralOutperformView details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/14/2026
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$20.24
-6.4%
5/14/2026Boost Price Target$19.00 ➝ $33.00OutperformView details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 5/14/2026
Tower Semiconductor Ltd. stock logo
TSEM
Tower Semiconductor
$283.43
+1.6%
5/14/2026Boost Price Target$140.00 ➝ $300.00NeutralView details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 5/14/2026
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
$14.33
-4.7%
5/14/2026Boost Price Target$15.00 ➝ $18.00NeutralView details for Wedbush rating of Vor Biopharma (NASDAQ:VOR) on 5/14/2026
Oracle Corporation stock logo
ORCL
Oracle
$192.13
+1.2%
5/13/2026Boost Price Target$225.00 ➝ $275.00OutperformView details for Wedbush rating of Oracle (NYSE:ORCL) on 5/13/2026
PepGen, Inc. stock logo
PEPG
PepGen
$1.51
-1.9%
5/13/2026Lower Price Target$5.00 ➝ $4.00OutperformView details for Wedbush rating of PepGen (NASDAQ:PEPG) on 5/13/2026
C3.ai, Inc. stock logo
AI
C3.ai
$9.30
-0.3%
5/13/2026Reiterated Rating$15.00OutperformView details for Wedbush rating of C3.ai (NYSE:AI) on 5/13/2026
DoubleDown Interactive Co., Ltd. Sponsored ADR stock logo
DDI
DoubleDown Interactive
$11.97
-1.2%
5/13/2026Lower Price Target$21.00 ➝ $15.00OutperformView details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 5/13/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$418.57
-0.1%
5/13/2026Reiterated Rating$575.00OutperformView details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 5/13/2026
Oklo Inc. stock logo
OKLO
Oklo
$65.76
+1.0%
5/13/2026Reiterated Rating$110.00OutperformView details for Wedbush rating of Oklo (NYSE:OKLO) on 5/13/2026
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
$6.62
+1.8%
5/13/2026Lower Price Target$17.00 ➝ $16.00OutperformView details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 5/13/2026
CI&T Inc. stock logo
CINT
CI&T
$3.37
-4.0%
5/12/2026Lower Price Target$9.00 ➝ $7.00OutperformView details for Wedbush rating of CI&T (NYSE:CINT) on 5/12/2026
EIKN
EIKN
$10.91
-2.2%
5/12/2026Lower Price Target$7.00 ➝ $5.00UnderperformView details for Wedbush rating of EIKN (NASDAQ:EIKN) on 5/12/2026
Getty Images Holdings, Inc. stock logo
GETY
Getty Images
$1.07
+2.4%
5/12/2026Reiterated Rating$7.00OutperformView details for Wedbush rating of Getty Images (NYSE:GETY) on 5/12/2026
National CineMedia, Inc. stock logo
NCMI
National CineMedia
$2.99
-0.3%
5/12/2026Lower Price Target$6.50 ➝ $6.00OutperformView details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 5/12/2026
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$12.60
+1.9%
5/12/2026Reiterated Rating$12.00NeutralView details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/12/2026
USA Rare Earth Inc. stock logo
USAR
USA Rare Earth
$25.30
+4.2%
5/12/2026Boost Price Target$29.00 ➝ $35.00OutperformView details for Wedbush rating of USA Rare Earth (NASDAQ:USAR) on 5/12/2026
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
$7.87
-1.5%
5/11/2026Boost Price Target$23.00 ➝ $40.00OutperformView details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 5/11/2026
Burford Capital Limited stock logo
BUR
Burford Capital
$4.53
-3.7%
5/11/2026Boost Price Target$4.75 ➝ $5.00NeutralView details for Wedbush rating of Burford Capital (NYSE:BUR) on 5/11/2026
CG Oncology, Inc. stock logo
CGON
CG Oncology
$64.25
-0.5%
5/11/2026Boost Price Target$77.00 ➝ $80.00OutperformView details for Wedbush rating of CG Oncology (NASDAQ:CGON) on 5/11/2026
General Motors Company stock logo
GM
General Motors
$78.81
+2.1%
5/11/2026Reiterated Rating$95.00OutperformView details for Wedbush rating of General Motors (NYSE:GM) on 5/11/2026
ImageneBio, Inc. stock logo
IMA
ImageneBio
$5.56
+0.7%
5/11/2026Reiterated RatingUnderperformView details for Wedbush rating of ImageneBio (NASDAQ:IMA) on 5/11/2026
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$22.21
-5.3%
5/11/2026Boost Price Target$24.00 ➝ $34.00OutperformView details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$66.61
-2.9%
5/11/2026Lower Price Target$95.00 ➝ $80.00NeutralView details for Wedbush rating of Nektar Therapeutics (NASDAQ:NKTR) on 5/11/2026
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th... (Ad)

After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as June 12th.tc pixel

Click here now to watch hall of fame trader Jon Najarian's full prediction.
The Trade Desk stock logo
TTD
Trade Desk
$22.38
+5.2%
5/8/2026Set Price Target$23.00 ➝ $21.00NeutralView details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 5/8/2026
Coinbase Global, Inc. stock logo
COIN
Coinbase Global
$184.99
-4.4%
5/8/2026 Set Price Target$224.00View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 5/8/2026
Apple Inc. stock logo
AAPL
Apple
$308.82
+1.3%
5/8/2026Reiterated Rating$350.00 ➝ $400.00OutperformView details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/8/2026
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
$13.84
-1.0%
5/8/2026Boost Price Target$36.00 ➝ $37.00OutperformView details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 5/8/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$11.00
+0.8%
5/8/2026Boost Price Target$15.00 ➝ $17.00OutperformView details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 5/8/2026
Corsair Gaming, Inc. stock logo
CRSR
Corsair Gaming
$7.70
+11.1%
5/8/2026Boost Price Target$7.00 ➝ $8.00OutperformView details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 5/8/2026
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$18.64
-3.4%
5/8/2026Lower Price Target$25.00 ➝ $23.00OutperformView details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 5/8/2026
Innodata Inc. stock logo
INOD
Innodata
$95.48
-3.1%
5/8/2026Boost Price Target$75.00 ➝ $80.00OutperformView details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/8/2026
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$14.52
+0.8%
5/8/2026Lower Price Target$45.00 ➝ $36.00OutperformView details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026
MP Materials Corp. stock logo
MP
MP Materials
$64.42
+4.3%
5/8/2026Boost Price Target$90.00 ➝ $100.00OutperformView details for Wedbush rating of MP Materials (NYSE:MP) on 5/8/2026
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$343.56
-2.0%
5/8/2026Boost Price Target$130.00 ➝ $166.00UnderperformView details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/8/2026
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
$6.10
+0.2%
5/8/2026Boost Price Target$8.00 ➝ $11.00OutperformView details for Wedbush rating of Shattuck Labs (NASDAQ:STTK) on 5/8/2026
Unity Software Inc. stock logo
U
Unity Software
$25.50
-0.2%
5/8/2026Boost Price Target$30.00 ➝ $32.00OutperformView details for Wedbush rating of Unity Software (NYSE:U) on 5/8/2026
AppLovin Corporation stock logo
APP
AppLovin
$481.68
-0.9%
5/7/2026Reiterated Rating$640.00OutperformView details for Wedbush rating of AppLovin (NASDAQ:APP) on 5/7/2026
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$8.29
-1.0%
5/7/2026Lower Price Target$22.00 ➝ $21.00OutperformView details for Wedbush rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2026
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
$13.05
5/7/2026Downgrade$15.00 ➝ $13.25OutperformHoldView details for Wedbush rating of Cross Country Healthcare (NASDAQ:CCRN) on 5/7/2026
Datadog, Inc. stock logo
DDOG
Datadog
$222.32
+2.0%
5/7/2026Boost Price Target$190.00 ➝ $220.00OutperformView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 5/7/2026
fuboTV Inc. stock logo
FUBO
fuboTV
$9.78
+7.0%
5/7/2026Lower Price Target$24.00 ➝ $19.00OutperformView details for Wedbush rating of fuboTV (NYSE:FUBO) on 5/7/2026
Qualys, Inc. stock logo
QLYS
Qualys
$102.37
+1.5%
5/7/2026Lower Price Target$155.00 ➝ $125.00OutperformView details for Wedbush rating of Qualys (NASDAQ:QLYS) on 5/7/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$151.56
-1.4%
5/7/2026Boost Price Target$165.00OutperformView details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026
TaskUs, Inc. stock logo
TASK
TaskUs
$6.16
+0.7%
5/7/2026Lower Price Target$14.00 ➝ $12.00OutperformView details for Wedbush rating of TaskUs (NASDAQ:TASK) on 5/7/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$16.35
-1.5%
5/6/2026Boost Price Target$29.00 ➝ $40.00OutperformView details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/6/2026
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$86.48
-3.5%
5/6/2026Boost Price Target$103.00 ➝ $105.00OutperformView details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 5/6/2026
Huron Consulting Group Inc. stock logo
HURN
Huron Consulting Group
$105.46
+0.1%
5/6/2026Reiterated Rating$160.00OutperformView details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 5/6/2026
International Business Machines Corporation stock logo
IBM
International Business Machines
$253.88
+0.4%
5/6/2026Reiterated Rating$320.00OutperformView details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/6/2026
Logitech International S.A. stock logo
LOGI
Logitech International
$112.63
+6.5%
5/6/2026Reiterated Rating$135.00OutperformView details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 5/6/2026
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$156.70
+0.8%
5/6/2026Boost Price Target$166.00 ➝ $176.00OutperformView details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
$99.19
-2.8%
5/6/2026Boost Price Target$112.00 ➝ $118.00OutperformView details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/6/2026
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
$23.39
-1.3%
5/6/2026Lower Price Target$27.00 ➝ $26.00NeutralView details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/6/2026
Super Micro Computer, Inc. stock logo
SMCI
Super Micro Computer
$35.58
+6.3%
5/6/2026Lower Price Target$42.00 ➝ $34.00NeutralView details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 5/6/2026
Paymentus Holdings, Inc. stock logo
PAY
Paymentus
$23.45
-0.1%
5/5/2026Boost Price Target$32.00 ➝ $36.00OutperformView details for Wedbush rating of Paymentus (NYSE:PAY) on 5/5/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$44.43
-0.7%
5/5/2026Boost Price Target$53.00 ➝ $55.00OutperformView details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2026
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$3.98
+2.8%
5/5/2026Reiterated Rating$11.00OutperformView details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 5/5/2026
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
$4.73
-1.4%
5/5/2026Reiterated Rating$11.00OutperformView details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 5/5/2026
Palantir Technologies Inc. stock logo
PLTR
Palantir Technologies
$136.88
-0.4%
5/5/2026Reiterated Rating$230.00OutperformView details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 5/5/2026
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$1.96
+1.0%
5/5/2026Initiated Coverage$6.00OutperformView details for Wedbush rating of Pyxis Oncology (NASDAQ:PYXS) on 5/5/2026
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
$41.13
-1.5%
5/5/2026Initiated Coverage$53.00OutperformView details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 5/5/2026
Airbnb, Inc. stock logo
ABNB
Airbnb
$132.35
-1.4%
5/4/2026 UpgradeNeutralView details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 5/4/2026
Advanced Micro Devices, Inc. stock logo
AMD
Advanced Micro Devices
$467.51
+4.0%
5/4/2026Boost Price Target$290.00 ➝ $400.00OutperformView details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 5/4/2026
GlobalFoundries Inc. stock logo
GFS
GlobalFoundries
$85.64
+5.3%
5/4/2026Reiterated Rating$50.00NeutralView details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 5/4/2026
IonQ, Inc. stock logo
IONQ
IonQ
$63.54
+7.9%
5/4/2026Reiterated Rating$60.00OutperformView details for Wedbush rating of IonQ (NYSE:IONQ) on 5/4/2026
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
$41.13
-1.5%
5/4/2026UpgradeStrong-BuyView details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 5/4/2026
TMC the metals company Inc. stock logo
TMC
TMC the metals
$5.40
+2.7%
5/4/2026Boost Price Target$8.00 ➝ $10.00OutperformView details for Wedbush rating of TMC the metals (NASDAQ:TMC) on 5/4/2026
Roblox Corporation stock logo
RBLX
Roblox
$48.23
+4.5%
5/1/2026 DowngradeHoldNeutralView details for Wedbush rating of Roblox (NYSE:RBLX) on 5/1/2026
Roblox Corporation stock logo
RBLX
Roblox
$48.23
+4.5%
5/1/2026Lower Price Target$90.00 ➝ $65.00OutperformView details for Wedbush rating of Roblox (NYSE:RBLX) on 5/1/2026
Check Point Software Technologies Ltd. stock logo
CHKP
Check Point Software Technologies
$133.63
+1.4%
5/1/2026Lower Price Target$210.00 ➝ $160.00OutperformView details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 5/1/2026
Rithm Capital Corp. stock logo
RITM
Rithm Capital
$9.27
+0.1%
5/1/2026Lower Price Target$14.00 ➝ $12.50OutperformView details for Wedbush rating of Rithm Capital (NYSE:RITM) on 5/1/2026
Roku, Inc. stock logo
ROKU
Roku
$125.55
+0.4%
5/1/2026Boost Price Target$140.00 ➝ $155.00OutperformView details for Wedbush rating of Roku (NASDAQ:ROKU) on 5/1/2026
Apple Inc. stock logo
AAPL
Apple
$308.82
+1.3%
5/1/2026Reiterated Rating$350.00OutperformView details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/1/2026
Fannie Mae stock logo
FNMA
Fannie Mae
$7.19
+0.4%
5/1/2026 Downgrade$8.00OutperformNeutralView details for Wedbush rating of Fannie Mae (OTCMKTS:FNMA) on 5/1/2026
SpaceX will mint billionaires. You won't be one of them. (Ad)

By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billion - you'd be buying at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's path, still priced like Wall Street hasn't noticed. It powers the infrastructure Musk's operation can't run without. Dylan Jovine is naming the ticker free - before the June S-1 closes the window.tc pixel

Get the ticker now before the June S-1 closes the window
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$6.75
+1.0%
5/1/2026Reiterated Rating$38.00OutperformView details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/1/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
$25.45
+1.1%
4/30/2026Lower Price Target$32.00 ➝ $27.00OutperformView details for Wedbush rating of Tenable (NASDAQ:TENB) on 4/30/2026
Silicon Motion Technology Corporation stock logo
SIMO
Silicon Motion Technology
$276.14
+4.8%
4/30/2026Boost Price Target$180.00 ➝ $230.00OutperformView details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 4/30/2026
Marcus Corporation (The) stock logo
MCS
Marcus
$18.11
-1.2%
4/30/2026Boost Price Target$22.00 ➝ $23.00OutperformView details for Wedbush rating of Marcus (NYSE:MCS) on 4/30/2026
Biogen Inc. stock logo
BIIB
Biogen
$193.76
+2.3%
4/30/2026Boost Price Target$191.00 ➝ $196.00NeutralView details for Wedbush rating of Biogen (NASDAQ:BIIB) on 4/30/2026
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$52.75
+0.8%
4/30/2026Lower Price Target$61.00 ➝ $56.00NeutralView details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/30/2026
Microsoft Corporation stock logo
MSFT
Microsoft
$418.57
-0.1%
4/30/2026Reiterated Rating$575.00OutperformView details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/30/2026
Unity Software Inc. stock logo
U
Unity Software
$25.50
-0.2%
4/30/2026Reiterated Rating$30.00OutperformView details for Wedbush rating of Unity Software (NYSE:U) on 4/30/2026
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
$4.52
-0.4%
4/29/2026Boost Price Target$8.00 ➝ $10.00OutperformView details for Wedbush rating of Aclaris Therapeutics (NASDAQ:ACRS) on 4/29/2026
Sandisk Corporation stock logo
SNDK
Sandisk
$1,478.69
-4.1%
4/29/2026Boost Price Target$740.00 ➝ $1,200.00OutperformView details for Wedbush rating of Sandisk (NASDAQ:SNDK) on 4/29/2026

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms in the last 90 days. Vote "Outperform" if you believe Wedbush's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES
30 Believe will outperform the market
UNDERPERFORM VOTES
27 Believe will underperform the market

Wedbush's equity research team has issued ratings on 280 companies across 14 sectors over the past 12 months, covered by 18 analysts. The Wedbush analysts below are listed by number of ratings issued in the last year.

Wedbush Stock Coverage by Sector

Wedbush concentrates its research most heavily in Medical (40.1%), Computer and Technology (27.3%) and Consumer Discretionary (6.7%). The chart below shows how Wedbush's 282 rated companies are distributed across all 14 sectors it covers.

Wedbush - Frequently Asked Questions

Wedbush's analysts currently have buy-equivalent ratings on 230 companies. Recent upgrades to buy include STAAR Surgical, Sionna Therapeutics, Rezolute and Cross Country Healthcare.

Wedbush's highest-rated analysts by MarketBeat's accuracy score include Laura Chico, Robert Driscoll and David Nierengarten. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 18 analysts at Wedbush.

Wedbush has the deepest coverage in Medical (40.1% of rated companies), Computer and Technology (27.3% of rated companies), Consumer Discretionary (6.7% of rated companies), Retail/Wholesale (6.4% of rated companies) and Finance (5.3% of rated companies).

Wedbush issued 918 ratings over the last 12 months across 282 companies — an average of roughly 76 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Wedbush analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Wedbush uses Outperform, Neutral, and Underperform as their equivalents.